COVID-19 due to the B.1.617.2 (Delta) variant compared to B.1.1.7 (Alpha) variant of SARS-CoV-2: a prospective observational cohort study

COVID-19 due to the B.1.617.2 (Delta) variant compared to B.1.1.7 (Alpha) variant of SARS-CoV-2: a prospective observational cohort study

Abstract The Delta (B.1.617.2) variant was the predominant UK circulating SARS-CoV-2 strain between May and December 2021. How Delta infection compares with previous variants is unknown. This prospective observational cohort study assessed symptomatic adults participating in the app-based COVID Symp...

Full description

Bibliographic Details
Main Authors:	Kerstin Kläser, Erika Molteni, Mark Graham, Liane S. Canas, Marc F. Österdahl, Michela Antonelli, Liyuan Chen, Jie Deng, Benjamin Murray, Eric Kerfoot, Jonathan Wolf, Anna May, Ben Fox, Joan Capdevila, The COVID-19 Genomics U. K. (COG-UK) Consortium, Marc Modat, Alexander Hammers, Tim D. Spector, Claire J. Steves, Carole H. Sudre, Sebastien Ourselin, Emma L. Duncan
Format:	Article
Language:	English
Published:	Nature Portfolio 2022-06-01
Series:	Scientific Reports
Online Access:	https://doi.org/10.1038/s41598-022-14016-0

Similar Items

Differences in Transmission between SARS-CoV-2 Alpha (B.1.1.7) and Delta (B.1.617.2) Variants
by: Camino Trobajo-Sanmartín, et al.
Published: (2022-04-01)

Insights into COVID-19 Delta variant (B.1.617.2)
by: Angel Yun-Kuan Thye, et al.
Published: (2021-11-01)

Analysis of the Delta Variant B.1.617.2 COVID-19
by: Shayan Shiehzadegan, et al.
Published: (2021-10-01)

Transmission of B.1.617.2 Delta variant between vaccinated healthcare workers
by: Steven A. Kemp, et al.
Published: (2022-06-01)

Large-scale synchronized replacement of Alpha (B.1.1.7) variant by the Delta (B.1.617.2) variant of SARS-COV-2 in the COVID-19 pandemic
by: Yuan Liu, et al.
Published: (2022-02-01)

Is the Delta Plus Variant (B.1.617.2/AY1) more serious than the Delta Variant?
by: Mohana Priya Kunasekaran, et al.
Published: (2021-12-01)

Reduced neutralisation of the Delta (B.1.617.2) SARS-CoV-2 variant of concern following vaccination.
by: Chris Davis, et al.
Published: (2021-12-01)

Neutralizing Activity of Sera from Sputnik V-Vaccinated People against Variants of Concern (VOC: B.1.1.7, B.1.351, P.1, B.1.617.2, B.1.617.3) and Moscow Endemic SARS-CoV-2 Variants
by: Vladimir A. Gushchin, et al.
Published: (2021-07-01)

Changing Features of COVID-19: Characteristics of Infections with the SARS-CoV-2 Delta (B.1.617.2) and Alpha (B.1.1.7) Variants in Southern Italy
by: Daniela Loconsole, et al.
Published: (2021-11-01)

Mortality among hospitalized COVID-19 patients during surges of SARS-CoV-2 alpha (B.1.1.7) and delta (B.1.617.2) variants
by: Alireza Zali, et al.
Published: (2022-11-01)

Specific Detection of SARS-CoV-2 Variants B.1.1.7 (Alpha) and B.1.617.2 (Delta) Using a One-Step Quantitative PCR Assay
by: Oran Erster, et al.
Published: (2022-04-01)

Characterization of SARS-CoV-2 Variants B.1.617.1 (Kappa), B.1.617.2 (Delta), and B.1.618 by Cell Entry and Immune Evasion
by: Wenlin Ren, et al.
Published: (2022-04-01)

SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion
by: Mlcochova, P, et al.
Published: (2021)

In Vitro Rapid Antigen Test Performance with the SARS-CoV-2 Variants of Concern B.1.1.7 (Alpha), B.1.351 (Beta), P.1 (Gamma), and B.1.617.2 (Delta)
by: Sabrina Jungnick, et al.
Published: (2021-09-01)

Genetic emergence of B.1.617.2 in COVID-19
by: L. Kirola
Published: (2021-09-01)

SARS-CoV-2 RT-PCR to Screen for B.1.617.2 (Delta) Variant of Concern
by: Kym Lowry, et al.
Published: (2022-08-01)

Effectiveness of COVID-19 Vaccines against Delta Variant (B.1.617.2): A Meta-Analysis
by: Rashidul Alam Mahumud, et al.
Published: (2022-02-01)

Comparative Sensitivity of Rapid Antigen Tests for the Delta Variant (B.1.617.2) of SARS-CoV-2
by: Yuko Sakai-Tagawa, et al.
Published: (2021-10-01)

Delta variant (B.1.617.2) of SARS-CoV-2: Mutations, impact, challenges and possible solutions
by: Manish Dhawan, et al.
Published: (2022-11-01)

Impact of inactivated COVID-19 vaccines on lung injury in B.1.617.2 (Delta) variant-infected patients
by: Miao Lai, et al.
Published: (2023-03-01)

Severe Breakthrough COVID-19 Cases during Six Months of Delta Variant (B.1.617.2) Domination in Poland
by: Piotr Rzymski, et al.
Published: (2022-04-01)

Severe breakthrough COVID-19 cases in the SARS-CoV-2 delta (B.1.617.2) variant era
by: Stephen Y Wang, et al.
Published: (2022-01-01)

SARS-CoV-2 infection in pediatric population before and during the Delta (B.1.617.2) and Omicron (B.1.1.529) variants era
by: Haifa Khemiri, et al.
Published: (2022-09-01)

It did not stop there: rapid substitution of circulating SARS-CoV-2 variant of concern B.1.1.7 (Alpha) by variant of concern B.1.617.2 (Delta) and further evolution of different Delta sublineages in Southern Saxony-Anhalt in late summer 2021
by: Glaß Markus, et al.
Published: (2022-02-01)

Handgrip strength as a prognostic factor for COVID-19 mortality among older adult patients admitted to the intensive care unit (ICU): a comparison Alpha (B.1.1.7) and Delta (B.1.617.2) variants
by: Sajjad Rostamzadeh, et al.
Published: (2024-08-01)

First Detection of SARS-CoV-2 Delta (B.1.617.2) Variant of Concern in a Dog with Clinical Signs in Spain
by: Leira Fernández-Bastit, et al.
Published: (2021-12-01)

Relationships between COVID-19 healthcare outcomes and county characteristics in the U.S. for Delta (B.1.617.2) and Omicron (B.1.1.529 and BA.1.1) variants
by: Alexander A. Bruckhaus, et al.
Published: (2023-11-01)

Comparative analysis of SARS-CoV-2 variants Alpha (B.1.1.7), Gamma (P.1), Zeta (P.2) and Delta (B.1.617.2) in Vero-E6 cells: ultrastructural characterization of cytopathology and replication kinetics
by: Debora Ferreira Barreto Vieira, et al.
Published: (2024-01-01)

Insights on the interaction of SARS-CoV-2 variant B.1.617.2 with antibody CR3022 and analysis of antibody resistance
by: Sandhya KS, et al.
Published: (2023-03-01)

Transmission chains of the first local outbreak cause by Delta VariantB.1.617.2 COVID-19 in Guangzhou, Southern China
by: Chun Chen, et al.
Published: (2024-01-01)

Infection and Transmission of SARS-CoV-2 B.1.617.2 Lineage (Delta Variant) among Fully Vaccinated Individuals
by: Leonardo C. Caserta, et al.
Published: (2022-10-01)

First Detection of SARS-CoV-2 B.1.617.2 (Delta) Variant of Concern in a Symptomatic Cat in Spain
by: Sandra Barroso-Arévalo, et al.
Published: (2022-04-01)

Variable neutralizing antibody responses to 10 SARS-CoV-2 variants in natural infection with wild- type (B.1) virus, Kappa (B.1.617.1), and Delta (B.1.617.2) variants and COVISHIELD vaccine immunization in India: utility of the MSD platform
by: Rajashree Patil, et al.
Published: (2023-06-01)

COVID-19 outbreak trends in South Africa: A comparison of Omicron (B.1.1.529), Delta (B.1.617.2), and Beta (B.1.351) variants outbreak periods
by: Syed Mahfuz Al Hasan, et al.
Published: (2022-07-01)

Rapid Global Spread of the SARS-CoV-2 Delta (B.1.617.2) Variant: Spatiotemporal Variation and Public Health Impact
by: Qi Shi, et al.
Published: (2021-07-01)

Effectiveness of COVID-19 Vaccines against Delta (B.1.617.2) Variant: A Systematic Review and Meta-Analysis of Clinical Studies
by: Ali Pormohammad, et al.
Published: (2021-12-01)

Olfactory dysfunction is more severe in wild-type SARS-CoV-2 infection than in the Delta variant (B.1.617.2)
by: Ludger Klimek, PhD, MD, et al.
Published: (2022-06-01)

The latent period of coronavirus disease 2019 with SARS‐CoV‐2 B.1.617.2 Delta variant of concern in the postvaccination era
by: Tao Ma, et al.
Published: (2022-07-01)

The SARS-CoV-2 Delta (B.1.617.2) variant with spike N501Y mutation in the shadow of Omicron emergence
by: Irma Salimović-Bešić, et al.
Published: (2022-12-01)

Clinical features and high-resolution chest computerized tomography findings of children infected by the B.1.617.2 variant of coronavirus disease 2019
by: Chuanjun Xu, et al.
Published: (2022-12-01)